Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

Early benefit assessment: is the Pharmaceutical Market Restructuring Act in Germany (AMNOG) a break on innovation?

 
  NEW ON THE MARKET
 

Thrombin inhibitor dabigatran (PRADAXA) for nonvalvular atrial fibrillation

Protease inhibitor boceprevir (VICTRELIS) for chronic hepatitis C

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Are pre-filled syringes without integrated needle protection obsolete?

 
  CURRENT ADR NETWORK REPORT
 

Liver damage with analgesic flupirtine (KATADOLON, generics)

 
  SIDE EFFECTS

E.g. clozapine (LEPONEX, generics): bedwetting with atypical antipsychotics in adults

QT interval prolongation with SSRI citalopram (CIPRAMIL, generics)

 
  ERRATUM regarding OPTAFLU
 
© arznei-telegramm 9/2011